Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetazolamide
ANA
arthralgia
blind spot, enlarged
carbonic anhydrase inhibitor
CAT scan
CAT scan, abnormal
CAT scan, venography
cerebral embolism
cerebral embolism, cardiac origin
cerebral venous thrombosis
cerebrospinal fluid, drainage of
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident
cerebrovascular accident, infancy and childhood
cerebrovascular accident, non atherosclerotic cause of
cerebrovascular accident, young adult
Clinical Pathologic Conference(C.P.C.)
congenital heart disease
congenital heart disease, CNS complications with
controversies in neurology
cough
dehydration
dieting
dizziness
dural sinus stenosis
dural sinus thrombosis
Eisenmenger's syndrome
embolism
embolism, paradoxical
embolism, septic
empty sella
empty sella syndrome
endovascular therapy
fatigue
fever
gadobutrol
gadolinium
gender
headache
headache, positional
headache, throbbing
hemiplegia
hypertrophic intracranial pachymeningitis
hypertrophic pachymeningitis, IgG4 related disease
hyperviscosity
hypoxia
IgG4-related disease
intracranial hypertension, benign
intracranial hypertension, benign, pathogenesis of
intracranial pressure, increased
lateral sinus
lateral sinus thrombosis
lip swelling
lumbar puncture
meningitis, aseptic
meningitis, noninfectious
mental retardation
misdiagnosis
mongolism
MRI
MRI, abnormal
MRI, artifacts
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, disappearing lesion on
MRI, false positive
MRI, optic nerve
MRI, serial
MRI, venography
neurologic disease, diagnoses of
normal
obesity
optic disc edema
optic nerve sheath fenestration
oral ulcerations
papilledema
patent ductus arteriosus
pitfalls
pleocytosis of cerebrospinal fluid
polycythemia, secondary
precipitating factors
prognosis
pruritus
pulmonary stenosis
retinal hemorrhages
reversible neurologic disorder
review article
rubella syndrome
seizure
shunt procedure, lumboperitoneal
shunt procedure, ventriculo-peritoneal
sigmoid notch sign
skin, lesions in neurologic disorders
stent, intracranial
stent, venous sinus
systemic lupus erythematosus
systemic lupus erythematosus, neurologic complications with
tetralogy of Fallot
tinnitus, pulsatile
tongue, ulcer
transposition of the great vessels
transverse sinus stenosis
treatment of neurologic disorder
tricuspid atresia
truncus arteriosus
ulcers, fingertip
valsalva maneuver
vasculitides
vasculitis, cutaneous
venogram, cerebral
venous sinus atresia
visual loss
visual loss, transient
weight loss
weight management
Showing articles 850 to 900 of 2016 << Previous Next >>

Brainstem Lesions in Diffusion Sequences of MRI Can be Reversible After Arterial Recanalization
Neurol 73:813-815, Vilas,D., 2009

Transcranial Ultrasound in Clinical Sonothrombolysis (TUCSON) Trial
Ann Neurol 66:28-38, Molina,C.A.,et al, 2009

Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
Stroke 40:3646-3678, Latchaw,R.,et al, 2009

Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants
Stroke 40:3547-3551, Rizos,T.,et al, 2009

Expansion of the Time Window for Treatment of Acute Ischemic Stroke with Intravenous Tissue Plasminogen Activator: A Science Advisory from the American Heart Association/American Stroke Association
Stroke 40:2945-2948, del Zoppo,G.J.,et al, 2009

MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009

Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients
Stroke 40:2611-2612,2615, Moonis,M., 2009

Is Intraarterial tPA Within 3 Hours the Treatment of Choice for Selected Stroke Patients? No
Stroke 40:2613-2614,2615, Lindley,R.I., 2009

Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009

Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis
Stroke 40:2438-2441, Lansberg,M.G.,et al, 2009

Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
Stroke 40:2594-2600, Saver,J.L.,et al, 2009

Effectiveness of Thigh-Length Graduated Compression Stockings to Reduce the Risk of Deep Vein Thrombosis After Stroke (CLOTS Trial 1): A Multicentre, Randomised Controlled Trial
Lancet 373:1958-1965,1923, The CLOTS Trial Collaboration, 2009

Reversible Cerebral Vasoconstriction Syndrome
Pract Neurol 9:256-267, Ducros,A. &Bousser,M.-G., 2009

Intravenous Thrombolysis in Stroke Attributable to Cervical Artery Dissection
Stroke 40:37772-3776, Engelter,S.,et al, 2009

A Matter of Taste
JNNP 80:139-140, Theys,T.,et al, 2009

Telemedicine Versus Telephone for Remote Emergency Stroke Consultations: A Critically Appraised Topic
The Neurologist 15:163-166, Capampngan,D.J.,et al, 2009

The Presentation and Clinical Course of Intracranial Developmental Venous Anomalies in Adults: A Systematic Review and Prospective, Population-Based Study
Stroke 40:1980-1985, Hon,J.M.L.,et al, 2009

Thrombolysis in Young Adults with Ischemic Stroke
Stroke 40:2085-2091, Putaala,J.,et al, 2009

Treatment of Atherosclerotic Intracranial Arterial Stenosis
Stroke 40:2257-2261, Turan,T.N.,et al, 2009

4.5 Hours: The New Time Window for Tissue Plasminogen Activator in Stroke
Stroke 40:2266-2267, Davis,S.M. &Donnan,G.A., 2009

Thrombolytic Therapy for Patients Who Wake-Up With Stroke
Stroke 40:827-832, Barreto,A.D.,et al, 2009

Thrombolysis in Childhood Stroke: Report of 2 Cases and Review of the Literature
Stroke 40:801-807, Arnold,M.,et al, 2009

Disappearing Hyperdense Middle Cerebral Artery Sign in Ischaemic Stroke Patients Treated with Intravenous Thrombolysis: Clinical Course and Prognostic Significance
JNNP 80:273-278,248, Kharitonova,T.,et al, 2009

Clinicopath Conf, Multiple Bilateral Cerebral Infarcts with Intracerebral Hemorrhage in Reversible Cerebral Vasoconstrictive Syndrome
NEJM 360:1126-1137, Case 8-2009, 2009

The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours: Randomized Controlled Trials Are Required to Change Clinical Practice
Stroke 40:1545, Donnan,G.A. &Davis,S.M., 2009

Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis
Stroke 40:1710-1720, Earnshaw,S.R.,et al, 2009

Identifying Patients at High Risk for Poor Outcomes After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke 40:1780-1785, Hallevi,H.,et al, 2009

Endovascular Treatment of Brain Arteriovenous Fistulas
AJNR 30:851-856, Lv,X.,et al, 2009

Contrast-Enhanced MR Angiography Is Not More Accurate than Unenhanced 2D Time-of-Flight MR Angiography for Determining >70% Internal Carotid Artery Stenosis
AJNR 30:761-768, Babiarz,L.S.,et al, 2009

Spinal Dural Arteriovenous Fistulas
AJNR 30:639-648, Krings,T. &Geibprasert,S., 2009

Diagnostic Value of Spinal MR Imaging in Spontaneous Intracranial Hypotension Syndrome
AJNR 30:147-151, Watanabe,A.,et al, 2009

Persistent Fainting After Implantation of a "Curative" Pacemaker
NEJM 360:88-89, Kasim,S.,et al, 2009

Use of MRI to Estimate the Therapeutic Window in Acute Stroke: Is Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch an EPITHET for Salvageable Ischemic Brain Tissue?
Stroke 40:333-335, Toth,G. &Albers,G.W., 2009

May-Thurner Syndrome in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 40:1502-1504, Kiernan, T.J.,et al, 2009

Rhinologic Symptoms and Quality-of-Life in Patients with Churg-Strauss Syndrome Vasculitis
Am J Rhinol 22:406-409, Srouji, I.,et al, 2008

Clinicopath Conf., Allergic Fungal Sinusitis
NEJM 359:2825-2833, Case 40-2008, 2008

Stroke and Multi-Infarct Dementia as Presenting Symptoms of Giant Cell Arteritis: Report of 7 Cases and Review of the Literature
Medicine 87:335-344, Solans-Laque,R.,et al, 2008

Magnetic Resonance Correlate of Hemiparesis in Posterior Cerebral Artery Infarction
J Stroke Cerebrovasc Dis 17:378-381, Finelli,P.F., 2008

Review of Tissue Plasminogen Activator, Ischemic Stroke, and Potential Legal Issues
Arch Neurol 65:1429-1433, Liang,B.A.,et al, 2008

Dural Arterivenous Shunts: A New Classification of Craniospinal Epidural Venous Anatomical Bases and Clinical Correlations
Stroke 39:2783-2794, Geibprasert,S.,et al, 2008

Thrombolysis with Alteplase 3-4.5 h After Ischaemic Stroke (SITS-ISTR): An Observational Study
Lancet 372:1303-1309, Wahlgren,N.,et al, 2008

Thrombolysis with Alteplase 3 to 4.5 Hours After Acute Ischemic Stroke
NEJM 359:1317-1329,1393, Hacke,W.,et al, 2008

Curable Cause of Paraplegia: Spinal Dural Arteriovenous Fistulae
Stroke 39:2756-2759, Aghakhani,N.,et al, 2008

Symptomatic Intracerebral Hemorrhage and Recanalization After IV rt-PA: A Multicenter Study
Neurol 71:1304-1312, Saqqur,M.,et al, 2008

Prognostic Significance of Blood Pressure Variability After Thrombolysis in Acute Stroke
Neurol 71:552-558, Delgado-Mederos,R.,et al., 2008

Treatment of Cervical Artery Dissection: A Systematic Review and Meta-Analysis
JNNP 79:11222-1127, Menon,R.,et al, 2008

Clinicopath Conference, Postpartum Renal Failure Due to Thrombotic Microangiopathy Associated With Antiphospholipid Antibodies
NEJM 358:275-289, Case 2-2008, 2008

Rapid Assessment of Perfusion-Diffusion Mismatch
Stroke 39:75-81, Butcher,K.,et al, 2008

Brain Parenchymal Signal Abnormalities Associated With Developmental Venous Anomalies: Detailed MR Imaging Assessment
AJNR 29:1317-1323, Santucci,G.M.,et al., 2008

MR Imaging-Based Decision in Thrombolytic Therapy for Stroke on Awakening: Report of 2 Cases
AJRN 29:1314-1316, Iosif,C.,et al., 2008



Showing articles 850 to 900 of 2016 << Previous Next >>